These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

172 related articles for article (PubMed ID: 16766335)

  • 21. Systemic sequential therapy of psoriasis: a new paradigm for improved therapeutic results.
    Koo J
    J Am Acad Dermatol; 1999 Sep; 41(3 Pt 2):S25-8. PubMed ID: 10459144
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Effectiveness of systemic treatment agents on psoriatic nails: a comparative study.
    Demirsoy EO; Kıran R; Salman S; Cağlayan C; Aktürk AS; Bayramgurler D; Bilen N
    J Drugs Dermatol; 2013 Sep; 12(9):1039-43. PubMed ID: 24002153
    [TBL] [Abstract][Full Text] [Related]  

  • 23. A randomized comparison of acitretin-narrow-band TL-01 phototherapy and acitretin-psoralen plus ultraviolet A for psoriasis.
    Ozdemir M; Engin B; Baysal I; Mevlitoğlu I
    Acta Derm Venereol; 2008; 88(6):589-93. PubMed ID: 19002344
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Cytotoxic and genotoxic effects of acitretin, alone or in combination with psoralen-ultraviolet A or narrow-band ultraviolet B-therapy in psoriatic patients.
    Silva FS; Oliveira H; Moreiras A; Fernandes JC; Bronze-da-Rocha E; Figueiredo A; Custódio JB; Rocha-Pereira P; Santos-Silva A
    Mutat Res; 2013 Apr; 753(1):42-7. PubMed ID: 23474391
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Acitretin is a safe treatment option for infantile pustular psoriasis.
    Ergin S; Ersoy-Evans S; Sahin S; Ozkaya O
    J Dermatolog Treat; 2008; 19(6):341-3. PubMed ID: 18608713
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Combining etanercept with traditional agents in the treatment of psoriasis: a review of the clinical evidence.
    Foley PA; Quirk C; Sullivan JR; Dolianitis C; Hack SP; Thirunavukkarasu K; Cooper AJ
    J Eur Acad Dermatol Venereol; 2010 Oct; 24(10):1135-43. PubMed ID: 20337816
    [TBL] [Abstract][Full Text] [Related]  

  • 27. [Biologics in the treatment of psoriasis].
    Dissemond J; Grabbe S
    MMW Fortschr Med; 2006 Sep; 148(38):42-4. PubMed ID: 17036963
    [TBL] [Abstract][Full Text] [Related]  

  • 28. The combination of oral acitretin and bath PUVA for the treatment of severe psoriasis.
    Muchenberger S; Schöpf E; Simon JC
    Br J Dermatol; 1997 Oct; 137(4):587-9. PubMed ID: 9390336
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Combining biologic therapies with other systemic treatments in psoriasis: evidence-based, best-practice recommendations from the Medical Board of the National Psoriasis Foundation.
    Armstrong AW; Bagel J; Van Voorhees AS; Robertson AD; Yamauchi PS
    JAMA Dermatol; 2015 Apr; 151(4):432-8. PubMed ID: 25517130
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Use of biological agents in patients with moderate to severe psoriasis: a cohort-based perspective.
    Jones-Caballero M; Unaeze J; Peñas PF; Stern RS
    Arch Dermatol; 2007 Jul; 143(7):846-50. PubMed ID: 17638727
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Secukinumab (Cosentyx°) and plaque psoriasis.
    Prescrire Int; 2017 Mar; 26(180):61-62. PubMed ID: 30730616
    [No Abstract]   [Full Text] [Related]  

  • 32. Acitretin in combination with UVB or PUVA.
    Lebwohl M
    J Am Acad Dermatol; 1999 Sep; 41(3 Pt 2):S22-4. PubMed ID: 10459143
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Acitretin: optimal dosing strategies.
    Ling MR
    J Am Acad Dermatol; 1999 Sep; 41(3 Pt 2):S13-7. PubMed ID: 10459141
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Use of alefacept and etanercept in 3 patients whose psoriasis failed to respond to etanercept.
    Krell JM
    J Am Acad Dermatol; 2006 Jun; 54(6):1099-101. PubMed ID: 16713481
    [TBL] [Abstract][Full Text] [Related]  

  • 35. The ACCEPT study: ustekinumab versus etanercept in moderate-to-severe psoriasis patients.
    Young MS; Horn EJ; Cather JC
    Expert Rev Clin Immunol; 2011 Jan; 7(1):9-13. PubMed ID: 21162644
    [TBL] [Abstract][Full Text] [Related]  

  • 36. The treatment of psoriasis with etretinate and acitretin: a follow up of actual use.
    Magis NL; Blummel JJ; Kerkhof PC; Gerritsen RM
    Eur J Dermatol; 2000; 10(7):517-21. PubMed ID: 11056421
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Biological therapy and nail psoriasis.
    Lawry M
    Dermatol Ther; 2007; 20(1):60-7. PubMed ID: 17403261
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Biologic therapy for psoriasis: a brief history, II.
    Tutrone WD; Kagen MH; Barbagallo J; Weinberg JM
    Cutis; 2001 Dec; 68(6):367-72. PubMed ID: 11775769
    [TBL] [Abstract][Full Text] [Related]  

  • 39. When there is no single best biological agent: psoriasis and psoriatic arthritis in the same patient responding to two different biological agents.
    Adişen E; Karaca F; Gürer MA
    Clin Exp Dermatol; 2008 Mar; 33(2):164-6. PubMed ID: 18257837
    [TBL] [Abstract][Full Text] [Related]  

  • 40. A global approach to psoriatic patients through PASI score and Skindex-29.
    Prignano F; Ruffo G; Ricceri F; Pescitelli L; Lotti T
    G Ital Dermatol Venereol; 2011 Feb; 146(1):47-52. PubMed ID: 21317856
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.